"A 15-year-old girl surnamed Lin in Penghu County received four doses of vaccine and suffered from hepatitis B. There are 19 similar cases in Tai'an Township, Miaoli County. What is the reason? The director of the health center, Kang Xiaoming, said he was not sure, and hoped that the Department of Health would control the disease. The Bureau assisted in understanding. (This is not unclear, it should be very clear, this has already indicated that the vaccine is ineffective, very clear and definite ㄚ.)"
Shi Wenyi, deputy director of the CDC, said yesterday that the CDC has not received relevant notifications, and will learn more about it and assist the local government to deal with it if necessary.
Kang Xiaoming said that about 21% of the people in Tai'an Township, Miaoli County suffer from hepatitis B and 24% suffer from liver C. In total, about one person in every two people in the township suffers from liver disease. The ratio of two to four is much higher.
In order to understand the effectiveness of hepatitis B vaccination, the health center conducted hepatitis screening for 315 students under the age of 15 in the township who had received four doses of hepatitis B vaccine in 1992. Nineteen of them were found to be infected. B liver. (This is evidence that vaccines don't work.)
Kang Xiaoming said that since 1992, he has tried to trace the cause from the families of 19 patients, but the parents of some patients have died, and it is impossible to know from the family medical history whether it was vertical infection in the mother's body or the memory of the vaccine failed.
He said that the rate of hepatitis B among schoolchildren in Tai'an Township is very high, and among the patients who were found to be "accidentally" infected with hepatitis B, two of the students' liver index soared to more than five times that of normal people. He has presented data on this abnormal situation to the CDC and the academic circle for reference many times at relevant meetings, but unfortunately there is no unit to do research so far. (All the funding providers for the research are from western pharmaceutical factories. This kind of research that is not conducive to western pharmaceutical factories will not receive financial support, so there is no unit to do research.)"
